A detailed history of J.W. Cole Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 7,509 shares of EXAS stock, worth $442,505. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,509
Holding current value
$442,505
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$42.43 - $70.83 $318,606 - $531,862
7,509 New
7,509 $511,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $5.83 Million - $8.36 Million
101,244 New
101,244 $1,000
Q3 2021

Oct 26, 2021

SELL
$90.24 - $124.05 $184,450 - $253,558
-2,044 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$93.66 - $139.27 $39,899 - $59,329
426 Added 26.33%
2,044 $254,000
Q1 2021

Apr 28, 2021

SELL
$116.57 - $155.01 $11,657 - $15,501
-100 Reduced 5.82%
1,618 $213,000
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $171,129 - $244,162
1,718 New
1,718 $228,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.